We have previously reported a protocol for the directed differentiation of human induced pluripotent stem cells to kidney organoids comprised of nephrons, proximal and distal epithelium, vasculature and surrounding interstitial elements. The utility of this protocol for applications such as disease modelling will rely implicitly on the developmental accuracy of the model, technical robustness of the protocol and transferability between iPSC lines. Here we report extensive transcriptional analyses of the sources of variation across the timecourse of differentiation from pluripotency to complete kidney organoid, focussing on repeated differentiations to day 18 organoid. Individual organoids generated within the same differentiation experiment show Spearman's correlation coefficients of >0.99. The greatest source of variation was seen between experimental batch, with the enrichment for genes that also varied temporally between day 10 and day 25 organoids implicating nephron maturation as contributing to transcriptional variance between individual differentiation experiments. A morphological analysis revealed a transition from renal vesicle to capillary loop stage nephrons across the same time period. Distinct iPSC clones were also shown to display congruent transcriptional programs with inter-experimental and inter-clonal variation most strongly associated with nephron patterning. Even epithelial cells isolated from organoids showed transcriptional alignment with total organoids of the same day of differentiation. This data provides a framework for managing experimental variation, thereby increasing the utility of this approach for personalised medicine and functional genomics.
Introduction
The analysis of genetic disease at a molecular level involves comparisons between primary cell types derived from affected and unaffected individuals. Such approaches face many challenges, not least of all the capacity for the cell type being examined to reflect the disease phenotype. The ability to derive induced pluripotent stem cells (iPSC) from any somatic cell of a patient (Takahashi et al. 2007 ), together with directed differentiation protocols to generate specific target cell populations, has provided a capacity to specifically model the cell types affected by the disease. This has proven effective in the case of cardiomyocytes and neurons for the validation of causative genes and the analysis of the specific effect on cellular function (Bellin et al. 2013; Kim et al. 2013; Phelan et al. 2016; Ardhanareeswaran et al. 2017; Aksoy et al. 2017) . The utility of such approaches has substantially improved in the case of monogenic conditions with the advent of CRISPR editing by facilitating the creation of isogenic corrected lines for direct comparison with mutant lines (Jang & Ye 2016; Paquet et al. 2016; Howden et al. 2017 ).
Recent iPSC differentiation protocols have been developed in which multiple component cell types arise and self-organise in a fashion similar to the developing tissue (Ader & Tanaka 2014; Huch & Koo 2015) . Protocols have now been reported for the generation of optic cup, pituitary cerebral cortex, intestine and stomach organoids (Suga et al. 2011; Eiraku et al. 2011; Spence et al. 2011; Nakano et al. 2012; Lancaster et al. 2013; Kadoshima et al. 2013; McCracken et al. 2014) . Unlike protocols generating a relatively homogeneous target cell type, such as cardiomyocyte or neuron, the cellular complexity of such structures increases the likelihood of substantial variation between individual experiments. This will be compounded when comparing distinct cell lines for disease modelling, even if these represent patient and isogenic control lines, as individual iPSC clones show variation in rates of cell proliferation and response to ligand that may not be associated with an inherited genetic defect. Indeed, organoid protocols also tend to involve many weeks of differentiation to reach such complex endpoints, with any variation in the differentiation process across that time period also contributing to experimental variation. Understanding the robustness and reproducibility of such differentiation protocols is therefore paramount.
We have recently developed a stepwise protocol for the generation of kidney organoids from human pluripotent stem cells (Takasato et al. 2015; Takasato et al. 2016) . During this differentiation protocol, we have attempted to move the cells in a stepwise manner through the developmental milestones required for kidney morphogenesis during normal fetal development. Using a monolayer culture format, an initial induction of the primitive streak is achieved via canonical Wnt signalling, intermediate mesoderm patterning via FGF9 signalling, and then a 3D aggregate is formed with nephrogenesis induced via a pulse of canonical Wnt signalling (Takasato et al. 2016) . The resulting organoids contain >9 distinct cell types, representing the key epithelial cell types of the forming filtration units, the nephrons (podocytes, parietal epithelium, proximal tubule, loop of Henle, distal tubule), together with collecting ducts, endothelium, pericytes and interstitial fibroblasts. While this differentiation protocol was based upon our understanding of mouse development, the presence of key morphological structures positive for common markers in mouse development supports the assumption of strong developmental congruence between mouse and human kidney development.
However, with such a large number of distinct cell types present, the possibility for simple variation in the relative proportions of each component cell type raises the challenge of experimental reproducibility or the capacity for identifying novel disease-associated transcriptional change.
In this study, we provide a more complete transcriptional and morphological evaluation of the protocol for generation of kidney organoids from human pluripotent cell lines. Using RNA sequencing (RNA-seq) to globally profile gene expression of whole kidney organoids, we examine the degree of variation between organoids within a single differentiation experiment, between different differentiation experiments, between different iPSC clones and from the epithelial compartment isolated from within organoids. Focussing on a single timepoint of differentiation (day 18), we show striking transcriptional correlation between all organoids analysed (r 2 >0.956), with the highest congruence between individual organoids within the same differentiation experiment (r 2 >0.997) and the lowest congruence (r 2 >0.923) resulting from batch effects likely to reflect media components, RNA extraction and library preparation. A rank list of the most variable genes aligns closely with temporal gene expression changes across the organoid differentiation protocol, suggesting that these transcriptional variations reflect differences in relative organoid maturation, particularly with respect to nephron morphogenesis. Profiling of LTL-enriched or EpCAM-enriched epithelial populations from within organoids showed strong alignment with total organoids of the same day of differentiation, suggesting that this approach to reducing cellular complexity continues to reflect stage of development. Finally, a comparison of organoids generated using genetically distinct control iPSC cell lines showed no greater variation between lines than between batches. In total, these analyses provide a bioinformatic framework for approaching disease modelling using such a complex model, highlighting the need to minimise batch to batch variation when generating organoids from distinct lines.
Results:
Temporal characterisation of in vitro human kidney organoid differentiation demonstrates an appropriate embryogenic differentiation program
The protocol previously developed for the production of kidney organoids commences with a single vial of single cell-adapted human iPSC plated onto matrigel, with this representing day -1. At Day 0, differentiation is commenced within fully defined APEL media together with a specific regime of small molecule and recombinant proteins across a total period of 25 days, at which point approximately 20-30 individual organoids are generated (Takasato et al. 2016) . We refer to this as one differentiation experiment. An initial intra-experimental evaluation, performed as a comparison between individual organoids from the point of aggregation (day 7) using RNAseq analysis, has previously been reported (Takasato et al. 2015) . This included the profiling of three replicate individual kidney organoids collected at the time of aggregation at day 7, +3 days, +11 days and +18 days (referred to here as day 7, 10, 18 and 25) (GEO accession GSE70101). Here, we retrospectively extended this dataset by collecting triplicate RNA samples at the beginning of culture (day 0, pluripotent stem cells at plating) and day 4 (end of CHIR induction). In this case, the triplicates examined represented individual wells from the same starting vial. The examined timepoints within this complete differentiation protocol are referred to as days 0, 4, 7, 10, 18 and 25 ( Figure 1A ). See 'Methods' for information regarding sample and library preparation for RNASequencing.
A multidimensional scaling plot based on the 500 most variable genes revealed very high congruence (Spearman correlation > 0.986) between all samples at each timepoint showing high reproducibility between organoids within a given differentiation experiment ( Figure 1B ,C). Two approaches were used to investigate the molecular changes occurring across the differentiation protocol; i) consecutive pair-wise gene expression comparisons to find those genes increasing or decreasing most between each timepoint and ii) unsupervised clustering of genes across time points to identify genes displaying synexpression.
While substantial changes in gene expression occurred between each consecutive timepoint ( Figure   1D ), these were most pronounced at the beginning of the protocol (induction of primitive streak), between day 4 and day 7 (formation of intermediate mesoderm), and day 10 and day 18 (kidney differentiation). The transition from day 0 to 4 (2160 genes up, 2267 genes down, |logFC| > 1, FDR < 0.05; Supplementary Table 1) mimics the induction of primitive streak, with early loss of epithelial markers (e.g. EPCAM, CDH1 and CAV1) and pluripotency markers (e.g. NANOG, SOX2, KLF4 and OCT4), with a concurrent increase in expression of posterior primitive streak markers (e.g. T, MIXL1, CDX1 and CDX2) and HOX genes ( Figure 1E ). WNT signalling pathways were strongly up-regulated at day 4 (p=1.96e-07, Supplementary Table 2) due to the addition of a GSK3beta inhibitor, CHIR99201, with strong up-regulation of the transcription factor SP5 (logFC = 12, FDR =1.16e-306), which is directly regulated via canonical WNT signalling (Fujimura et al. 2007 ). Enriched GO terms for the top 100 up-regulated genes between day 4 and day 0 included somitogenesis, anterior/posterior pattern specification and regionalisation ( Figure   1F , Supplementary and SP5 significantly down-regulated. PAX8 and LHX1, which are essential for intermediate mesoderm induction (Tsang et al. 2000; Bouchard et al. 2002; Wang et al. 2005) , were significantly up-regulated across this time period while markers present in metanephric mesenchyme and ultimately in the nephrogenic mesenchyme, such as MEOX1/2, EYA1, SIX1/2, WT1 (Brunskill et al. 2008) , were also strongly up-regulated by day 7 (all logFC > 6.8). The most down-regulated genes between day 4 and 7 included primitive streak / definitive mesoderm markers CDX1, MIXL1
and T as well as FGF19, FGF17 and MYH6. GO terms involved in urogenital system development, kidney development, renal system development, and kidney epithelium development are significantly over-represented for the top 100 up-regulated genes between day 4 and day 7 ( Figure   1F , Supplementary Table 2 ).
Between day 7 and 10, there were fewer genes differentially expressed (731 up-regulated, 617
significantly down-regulated, |logFC| > 1, FDR < 0.05, Supplementary (Brunskill et al. 2011) .
Simultaneous with the upregulation of nephron markers between day 10 and 18 was the downregulation of markers of progenitor mesenchyme, including LIN28A, MEOX1, CITED1 and EYA1. GO terms over-represented for the top 100 up-regulated genes include nephron development, urogenital system development and kidney development ( Figure 1F , Supplementary Table 2 ).
Our second approach to the analysis of the molecular program across the entire time series was to look for synexpression clusters. This analysis allowed for clusters of genes to be identified with non-linear expression patterns across the time course. Genes were selected that showed expression changes across any time point across the time course (ranked by F-statistic, |logFC|>1). Fuzzy clustering was then performed allowing for 20 expression clusters to be identified (Supplementary Figure 1) , and core contributing genes with high membership scores (>0.5) for each cluster were extracted (Supplementary Table 3 ). Clusters of interest are show in Figure 2A . PCR for selected genes within clusters 5, 6, 7, 10, 14, 16 and 17 validated these patterns of gene expression in independent differentiations ( Figure 2B ).
In many instances, core genes in a given cluster are easily associated with anticipated profiles across a presumptive stepwise differentiation from pluripotency to kidney. For example, cluster 15 genes (including NANOG and SOX2) were highly expressed at day 0 and subsequently lost expression from day 4 onwards, indicative of a loss of pluripotency ( Figure 2A ). Cluster 7 included loss of expression of epithelial genes, such as EPCAM, as the pluripotent stem cells began differentiation (days 0 to 4) which then returned as nephrons arose within the organoids ( Figure 2A ). Genes in cluster 14 were activated from day 4 onwards, and included PAX2, an early marker of intermediate mesoderm ( (Table 1, Supplementary Table 5 ). These included MYCN in cluster 3, MAFB and HNF1A in cluster 10, NR3C1 and IRF2 in cluster 11, PAX2 in cluster 14, SOX2, FOXD3, INSM1
and SPIB in cluster 15, EBF1, NR2F1 and HNF1B in cluster 17 and TCF3 in cluster 19. This dataset will facilitate analysis of transcriptional networks driving synexpression within these clusters.
Analysis of the source of transcriptional variation between organoids within and between experiments
The cellular complexity present within an individual kidney organoid is likely to result in significant technical and biological variation. This is a particular challenge for disease modelling where variation unassociated with the disease state may exist. Sources of variation can arise from biological variation intrinsic to cell line or clone and technical variation resulting from vial / passage, batch variation in culture components and variations in downstream processing procedures. While correlation between organoids generated within the initial differentiation experiment was very high (r 2 >0.986), we wanted to understand the level of transcriptional variability that could arise when differentiation experiments are repeated. Using the same cell line as used in the time series RNAseq study, CRL1502-C32, organoids (18 in total) were generated from another 6 differentiation experiments with RNA collected from individual organoids at day 18 of culture ( Figure 3A ). These distinct differentiation experiments were also performed across a total of 12 months and hence across different reagent batches (culture media, recombinant growth factors). Organoids from experiments 3, 4 and 5, while all commencing with a distinct vial of starting iPSC, were all differentiated in parallel, and hence were classed as one "batch" ( Figure 3A ).
RNA isolation, library preparation and sequencing were also performed at the same time for these three experiments. The remaining organoids from experiments 1, 2, 6 and 7 were differentiated at different times, and considered to be distinct batches. All samples were sequenced at the same facility using the same protocol (see Methods).
Day 18 organoids differentiated in the same batch were highly concordant, with tight clustering shown on a multi-dimensional scaling plot that included the time course data ( Figure 3B ). Overall, the transcriptional correlation between all day 18 organoids generated across all batches was also very high (average Spearman's correlation = 0.956), with the highest correlation observed between organoids differentiated at the same time (average Spearman's correlation = 0.997, Figure organoids were positioned between day 10 and day 25 on a multi-dimensional scaling plot, with batch 3 organoids closer to day 10 organoids compared to the remaining organoids ( Figure 3B ).
Our experimental design allowed us to explore three levels of variability; (i) batch to batch variability, which captures variation arising due to performing differentiation experiments at different points in time; (ii) vial to vial variability for organoids differentiated in parallel in batch 3;
and finally (iii) organoid to organoid variability and all other unknown sources of variation, referred to here as residual variation. For each gene, a random effects analysis was performed which allowed us to obtain an estimate of the contribution of these three sources of variability, referred to here as variance components (Supplementary Table 6 ). Across all genes, the largest contribution to the transcriptional variability observed was batch to batch variability, with vial to vial variability only a small contributor and residual varance being minimal ( Figure 3D ).
Genes with the largest total variability between batch were examined in order to gain an understanding of how the variability in the transcriptional profiles between the day 18 organoids may arise. Many of the top most variable genes were related to nephron maturation (NPHS2, PTPRO, NPHS1) with these genes following a strikingly similar expression pattern across the batches ( Figure 3E ). Examining the top 50 most variable genes from the day 18 organoids (Supplementary Figure 3) across the original time course data showed a highly consistent temporal expression pattern, with low/no expression from day 0 to day 10, followed by a dramatic increase in expression coincident with nephron formation (from day 10 onwards) ( Figure 4A ). In line with this, the top 50 most variable genes were enriched in synexpression clusters 10 and 12 (7 genes in cluster 10, 16 in cluster 12, Supplementary Figure 4) .
In order to test whether the highly variable genes were related to nephron maturation, we performed differential expression testing between days 10 and 25 in the original time course data to indicate nephron formation related changes. The top 500 most highly variable genes between organoids at day 18 were strongly enriched for these nephron-related genes, with approximately 80% of the variable genes significantly up-regulated between day 10 and day 25 (p-value = 0.0005, ROAST test, Figure 4B ). 10 genes were identified that were most linearly associated with a developmental progression from day 7 to day 25 of differentiation ( Figure 4C ). Using these 10 genes, a multivariate linear regression was constructed for the day 7 to 25 time series data to obtain regression coefficients. Defining the additional day 18 organoids as new sample data, the normalised "age" of any given organoid relative to the time series data was calculated ( Figure 4D ).
This analysis mirrored the trend seen in the multi-dimensional scaling plots, with batch 3 organoids having the youngest predicted ages (10.3-11 days) and the remaining organoids batches (1, 2, 4 and 5) closer in developmental age to day 18 (median predicted ages: batch 1 = 17.1, batch 2 = 17.9, batch 4 = 15.5, batch 5 = 16.5). This approach may be applicable for normalisation of variation between kidney organoid batches for a given iPSC line.
Morphological and transcriptional evidence for nephron patterning in organoids between day 10 and day 25
The morphology of the forming nephron has been well documented in mouse (Little et al. 2007; Harding et al. 2011 ) with the definition of distinct stages of nephron patterning and segmentation defined ( Figure 5A ). Nephrons arise via a mesenchymal to epithelial transition as an initial pretubular aggregate (PTA) forms an epithelial renal vesicle (RV; Stage I nephron) which almost immediately displays definitive distal (JAG1, LHX1) and proximal (WT1) gene expression (Georgas et al. 2009 ) ( Figure 5A ). These structures undergo elongation to form comma-shaped (CSB) and then S-shaped bodies (SSB; Stage II nephrons). The SSB show expression of distinct medial segment markers with JAG1 expression becoming medial (Georgas et al. 2009; Lindström et al. 2015) . Involution of the proximal end of the elongating nephron to form the glomerular cup into which endothelial and mesangial cells migrate represents the capillary-loop stage (CL; Stage III) nephron (Georgas et al. 2009 ) ( Figure 5A ). In the Trimester 1 human kidney, very similar structures have been described (O'Brien et al. 2016) . However, in both mouse and human, these arise at stereotypical locations adjacent to a dichotomously branching ureteric epithelium. Using co-immunofluorescence for distal (CDH1), medial (JAG1) and proximal (WT1/NPHS1) protein markers, we examined the structures present within human kidney organoids from day 10 to 25 for evidence of normal patterning and segmentation ( Figure 5B ). No evidence for epithelial structures was present before day 10 ( Figure 5D ), at which time PTA and RV became readily observable ( Figure 5BD ). This was followed by a subsequent elongation and segmentation of epithelial units until, by day 18, most structures represented late-SSB to CL ( Figure 5BC ). JAG1 protein clearly moved from the distal RV to the medial SSB / CL nephron, as has been described in mouse (Lindström et al. 2015) . This analysis suggests that the formation of a nephron from PTA to CL takes approximately 6 to 8 days, as has been described in the developing human kidney (O'Brien et al. 2016) . In vivo, the collecting duct epithelium is present before nephrons arise and the forming nephrons invade the collecting duct tip to form a contiguous epithelium (Georgas et al, 2009 ).
Notably, a detailed evaluation of the GATA3+ECAD+ epithelium suggests that this arises in association with the forming nephrons rather than representing a distinct epithelial structure which fuses with the nephrons ( Figure 5D ). Indeed, some forming epithelial structures appear to have branching structures which are GATA3+ECAD+ epithelium that may represent the distal invading tip unit ( Figure 5E ). Unlike the developing organ in vivo, there was little evidence of continued nephron formation in these kidney organoids. Rather, the initial induction events appeared to give rise to early nephrons that then mature.
Overall, this morphological analysis supports the concept that substantial transcriptional variation between day 10 and day 25 is in large part due to variation in relative nephron maturation or nephron number. In order to analyse this in a more qualitative fashion, RNA was collected from day 14, 18, 20, 22 for qPCR of core genes implicated in nephron maturation (cluster 10 and 12), mesenchyme-to-epithelium transition (MET) (cluster 7), nephrogenesis (cluster 11), renal interstitium development (cluster 13), nephron commitment (cluster 17) and renal fate specification (cluster 20) (Figure 2A ). This analysis showed an increase in nephron and stromal gene expression with time and a concomitant reduction in metanephric mesenchymal markers ( Figure 5F ), again supporting the hypothesis of gradual nephron patterning and maturation across this period of time.
Correlation between kidney organoids generated using distinct iPSC clones
All the data presented thus far was collected from differentiations performed using a single human iPSC clone, CRL1502-C32 (Briggs et al. 2013 ). This line was derived from fetal fibroblasts collected from a normal female using footprint-free episomal reprogramming (Yu et al, 2009 ). To examine the experimental variation arising from a distinct iPSC clone with a different genome, kidney organoids generated from another female control human iPSC line, RG_0019.0149.C6, were also generated. The resulting organoids displayed a similar morphology to CRL1502-C32 at the level of immunofluorescence (Supplementary Figure 5) . RNA-seq profiling of organoids from this line was performed on two day 18 organoids from each of three separate but simultaneous differentiation experiments (6 organoids in total). In addition, triplicate day 0 and day 7 cultures of RG_0019.0149.C6 were profiled, one from each differentiation experiment. Combining organoids from both RG_0019.0149.C6 and CRL1502-C32 revealed striking concordance across the differentiation protocol, with organoids clustering based on differentiation duration and not cell line ( Figure 6A ). Day 18 organoids from RG_0019.0149.C6 clustered between CRL1502-C32 batch 3 and the remaining batches ( Figure 6A ). Spearman's correlation for each pairwise organoid across the time series and across the two cell lines again showed that organoids at the same time point were more highly correlated than organoids within each cell line between the time points ( Figure   6B ). This confirmed that batch effects are higher contributors to variation than genetic background or individual iPSC clone. All differentiations using this second line represented a single batch as all were differentiated simultaneously. It was possible, however, to examine gene-wise variation arising from distinct vials of the same line as well as any residual (kidney-kidney plus unknown) variation at day 18. Organoids grown from the same vials of RG_0019.0149.C6 were highly correlated ( Figure 6C , mean Spearman's correlation = 0.998), with this correlation remaining high between organoids grown from different vials of the same clone ( Figure 6C , mean Spearman's correlation = 0.997). As for the CRL1502-C32 organoids, a random effects analysis showed that the vial contribution was relatively small across all genes, with the residual variation contributing more transcriptional variability in general ( Figure 6E , Supplementary Table 7) . However, the most highly variable genes could be attributed to vial-to-vial variability, with differences driven by organoids Table 8 ).
The differences between the day 18 organoids from the two different cell lines could again be associated with the relative degree of maturation of the organoids, rather than genotype differences.
We defined a set of maturity-related genes by performing differential expression analysis between day 18 and day 10 of the original time course data. Performing unsupervised clustering of all day 18 organoids using the top 100 maturity related genes indicated that RG_0019.0149.C6 day 18
organoids were "older" than batch 3 CRL1502-C32 day 18 organoids, but "younger" than the remaining CRL1502-C32 organoids (batches 1, 2, 4 and 5; Figure 6D ). In addition, we performed a differential expression analysis between RG_0019.0149.C6 day 18 organoids and CRL1502-C32 day 18 organoids from Batch 3 that were generated with the same replication design. This gave us a set of up-and down-regulated genes differentially expressed between the two cell lines at day 18.
These genes were highly enriched in the set of maturity-related genes ( Figure 6F , ROAST p-values = 0.0005).
Epithelial-enriched populations isolated from organoids cluster with age-matched total organoids
The variation in global transcriptional profile between individual experiments even within the same cell line is likely to be exacerbated by the diversity of cell types present. In order to simplify the pool of cells being analysed, we also performed MACs-enrichment of the EpCAM + epithelial fraction of organoids generated from the RG_0019.0149.C6 cell line, and the LTL + epithelial fraction from the CRL1502-C32 cell line, both at day 25 of organoid differentiation. Multidimensional scaling analysis across the first two dimensions showed that both of the epithelialenriched profiles clustered alongside the global organoid profile of the same differentiation time point, illustrating the contribution of this cell type to the global profile ( Figure 6G ). Plotting the lower dimensions showed separation of total organoid and epithelium-enriched samples ( Figure   6G ). Plotting the log-normalised expression of a set of selected epithelial and stromal markers confirmed high expression of epithelial-enriched profiles ( Figure 6H ) and depleted expression of interstitial markers in both epithelium-enriched populations ( Figure 6I ). The LTL fraction showed distinctly higher expression of JAG1 consistent with the selective enrichment of the proximal tubular epithelium (LTL+) versus all epithelium (EpCAM+). While this approach will not overcome inherent differences in nephron maturation between batches, it does reduce the complexity of the transcriptional profile potentially improving the capacity to identify cell-type specific transcriptional changes. Such an approach is likely to assist in disease modelling.
Discussion:
The prospect of applying organoids to disease modelling or the analysis of morphogenesis in vitro rests implicitly on the accuracy of the model and the robustness and reproducibility of the protocol within and between lines. This becomes an even greater challenge with the cellular complexity of an organoid versus a relatively homogeneous cellular endpoint. Kidney organoids represent arguably the most complex human organoid generated to date. With this increased cellular complexity comes challenges in terms of variation in degree of cell patterning or relative proportions of cell types between experiments.
Despite this challenge, in this study we report transcriptional profiling of 51 kidney organoids, including whole and fractionated samples, and show a remarkable degree of congruence in profiles between organoids generated across considerable technical and biological variation. Overall, this analysis revealed that transcriptional variation is greatest between experimental batch. This strongly implicates technical variables that may include changes in batch of media, growth factors, RNA isolation reagent and cDNA library preparation. An analysis of the most variable genes between batch showed strong congruence with temporally variable genes associated with the period of nephron formation. We hypothesise that this results from variation in relative maturation between differentiation experiments, even using the same cell line. However, it is also possible that this reflects differences in the segmentation of individual nephrons within a given organoid and/or variations in the relative amounts of nephron versus non-nephron cell types in different organoids.
Indeed, there appears to be greater variation between distinct organoid batches than between different starting cell lines, implying that the greatest source of variation is in the reagents used during culture. Hence, variation at day 18 may also reflect subtle shifts in patterning across the entire differentiation.
While the robustness of the kidney organoid protocol would suggest that disease modelling may be feasible, it also identifies the challenges of comparisons performed between individual patient and control cell lines. Analysis of the sources of variation has allowed us to identify a set of 10 genes that facilitate a retrospective estimation of relative organoid 'age' for any given experiment. As this is a post hoc analysis, this does not ensure that lines to be compared will all reach the same level of maturation. It is possible to exclude the most variable genes from any transcriptional comparison, however this may also remove information of relevance to the phenotype of a particular line.
Another approach to reducing technical variation is to select for specific cell types from within the organoid. As a proof of concept, we report here the profiling of epithelial cells enriched from organoid cultures via magnetic sorting for two different markers of the epithelial phenotype. While we could show that these were enriched for epithelial markers, and depleted for stroma, they still aligned most closely with total organoids matched for differentiation stage with the organoids from which the epithelium was sourced. Therefore, analysis of selected cellular components from within organoids is likely to improve comparative phenotyping.
As the greatest source of variation appears to arise from differences in technical parameters, rather than cell line, cellular compartment or individual organoid, this would suggest that any comparisons between patient and control lines must be performed concurrently with as many technical variables controlled as possible. To assist in normalisation, we provide a list of genes that are most variable between batches at a single timepoint. Utilising this list of variable genes can also be performed to generate an estimate of relative organoid maturity, but this does not provide a solution if disease versus control lines repeatedly show differences in relative maturation state. Despite these challenges, we have successfully identified disease-related transcriptional changes between a patient and CRISPR-edited isogenic control line by removing from the analysis the 500 most variable genes identified in this study (Forbes et al, submitted) .
In summary, this study demonstrates that directed differentiation of human iPSC to kidney organoid is robust, reproducible and transferable between different pluripotent stem cell lines. This is the first detailed analysis of its type of the sources of transcriptional variation in a complex multicellular organoid model. The implications of this study are significant with respect to what this variation means for the design of disease modelling studies. As the greatest source of variation appears to arise from differences in technical parameters, rather than cell line, cellular compartment or individual organoid, this would suggest that any comparisons between patient and control lines must be performed concurrently with as many technical variables controlled as possible.
Methods:
Human pluripotent stem cell derivation and directed differentiation to kidney organoids.
Human induced pluripotent stem cells were generated using Sendai reprogramming as previously described. CRL1502.C32 is a female human iPSC line derived from ATCC CRL-1502 fetal fibroblasts (Briggs et al. 2013 ). RG_0019.0149.C6 is a female human iPSC line derived from fresh skin fibroblasts harvested from an adult. The protocol for directed differentiation to kidney organoid has been previously described (Takasato et al. 2015; Takasato et al. 2016 ).
RNA sequencing, data acquisition, alignment and QC
RNA from 51 kidney organoid differentiations was extracted using the QIAGEN RNeasy micro kit and sequencing libraries prepared using the standard Illumina protocols. For epithelial fractions, these were obtained from pooled organoids from the same differentiation. All samples were sequenced at the Institute for Molecular Bioscience in Queensland, Australia. The STAR aligner (v2.4.0h1) (Dobin et al. 2013 ) was used to map the 75bp single end reads to the human reference genome (hg19) in the two pass mapping mode. Uniquely mapped reads were summarised across genes with feature Counts (v1.4.6) (Liao et al. 2014 ) using Gencode Release 19 comprehensive annotation. Subsequent analyses of the count data were performed in the R statistical programming language using the Bioconductor (Gentleman et al. 2004 ) packages edgeR , limma (Ritchie et al. 2015) , RUVSeq (Risso et al. 2014 ), Mfuzz (Futschik & Carlisle 2005) , the annotation package org.Hs.eg.db; as well as the lme4 R package (Bates et al. 2015) . Highly expressed genes were defined as having at least one count per million in at least two or three samples and were retained for statistical analysis. The threshold for selecting highly expressed genes is determined by the minimum group sample size in the dataset being analysed. In addition, genes encoding for ribosomal protein, mitochondrial genes, pseudogenes genes and genes without annotation were removed prior to TMM normalisation (Robinson & Oshlack 2010 ) and statistical analysis.
Differential expression analysis of time series data
The time series RNA-Seq data consists of three replicates at each of six time points: Day 0, Day 4, Day 7, Day 10, Day 18 and Day 25. The samples for Days 7, 10, 18 and 25 were obtained and sequenced together, with additional data for the earlier time points, Days 0 and 4, generated at a later date. In order to account for possible batch effects, the differential expression analysis was performed using RUVSeq in conjunction with edgeR. RUVSeq was performed using empirical control genes, identified as the 5000 genes that varied the least across the time course data, based on an F-statistic. Genes that were differentially expressed at consecutive time points were identified as those that had an adjusted false discovery rate of less than 5%. Genes significantly differentially expressed with an absolute logFC of at least one and false discovery rate less than 5% were identified with a TREAT analysis (McCarthy & Smyth 2009 ). Gene ontology testing was performed using the goana function in limma, adjusting for gene length bias (Young et al. 2010) , as well as the web-based ToppGene suite (Chen et al. 2009 ).
Multidimensional scaling plots and unsupervised clustering
For all datasets, multidimensional scaling plots based on the top 500 most variable genes were used to visualise the greatest sources of variation, specifying pairwise distance metrics in the limma package. Genes that displayed similar patterns of expression across the time course data were clustered using fuzzy c-means clustering. The clustering was limited to genes that showed evidence of differential expression across the time course based on an F-statistic, and with an absolute logFC of at least one between at least one comparison. For this analysis, each time point was compared to the remaining time points. This identified 7682 genes to use as input for the Mfuzz algorithm. The counts were transformed to log counts per million, adding a small offset of 0.25 proportional to the library sizes. Each of the three replicates were averaged per time point, and the data standardised such that each gene had a mean of zero and standard deviation of one to ensure genes with similar changes in expression are close in Euclidean space. The soft clustering approach assigned each gene gradual degrees of membership, ranging from zero to one, to each of the 20 clusters. A core set of genes for each cluster was identified by specifying a cut-off on the membership score of 0.5, with numbers of core genes per cluster ranging from 70 to 299. Gene ontology and KEGG pathway analysis on the core genes was performed using the goana and kegga function in limma, adjusting for gene length bias (Young et al. 2010) , and further explored using the ToppGene suite.
Transcription factor analysis
Transcription factors for hg19 were downloaded from the FANTOM5 website (http://fantom.gsc.riken.jp/5/sstar/Browse_Transcription_Factors_hg19). The R packages JASPAR2016 and TFBSTools (Tan & Lenhard 2016) were used to explore binding site hits for selected motifs in the core genes for each of the fuzzy clusters.
Random effects modelling
In order to study the different variance components when comparing across experiments and batches a multi-level random effects model was fitted to the Day 18 organoid data for each cell line separately using the lmer function in the lme4 R package. The data was transformed to log counts per million adding a small prior count of 0.5 before model fitting, and variance components for experiment, vial and residual extracted for the CRL1502-C32 organoids, and vial and residual components extracted for the RG_0019.0149.C6 organoids. Genes were ranked according to total variation, which was obtained by summing the variance components. For each gene, the greatest contributor to the variability was obtained by calculating proportions of each variance component to the total variation.
Bright Field Imaging and Immunofluorescence Imaging of cultures
Bright field images were taken using the Nikon TS-1000 inverted microscope. For the kidney organoid, antibody staining was performed as described previously (Takasato et al., 2016) . The following antibodies and dilutions were used: mouse anti-ECAD (1:300, 610181, BD Biosciences), goat anti-GATA3 (1:300, AF2605, R&D Systems), sheep anti-NPHS1 (1:300, AF4269, R&D Systems), LTL-biotin-conjugated (1:300, B-1325, Vector Laboratories) and rabbit anti-Jagged1
(1:300, ab7771, Abcam). Confocal imaging was performed using a Zeiss LSM780 scanning confocal, with a Zeiss Plan-Apochromat 25x, 0.8NA multi-immersion objective. Confocal stacks were taken at 1.5 micron Z spacing and exported to Imaris (Biplane) for 3D reconstruction and surface rendering. All other image processing was performed in Fiji (Schindelin et al, Nature
Methods, PMID: 22743772). All immunofluorescence analyses were successfully repeated more than three times and representative images are shown.
QPCR of organoids
Total RNA was extracted from cells using Purelink RNA mini kit (Life Technologies) and cDNA was synthesized from 100 ng total RNA using GoScript TM reverse transcriptase (Promega Australia). qRT-PCR analyses were performed with GoTaq qPCR Master Mix (Promega) by an ABI PRISM 7500 96 real-time PCR machine. All absolute data were first normalized to GAPDH and then normalized to control samples (DDCt method). The sequences of primers used for qRT-PCR are as listed in Supplementary Table 9 .
Isolation of EpCAM-enriched cellular fractions
Kidney organoids were transferred to a drop of trypsin-EDTA, minced with a surgical blade, transferred to a 15 ml tube with 3 ml trypsin-EDTA and incubated at 37 C for 10 min while gently pipetting the disintegrating organoid pieces every 3 minutes. Next 8 
Isolation of LTL-enriched cellular fractions
Pooled iPSC-derived kidney organoids were dissociated by incubation with TrypLE select enzyme (Thermo Fisher) for 12 minutes at 37°C, with gentle pipetting every 2 minutes to aid dissociation.
The cell solution was passed through a series of cell strainers with sequentially smaller mesh sizes, ranging from 100µM to 40µM (Corning) with extensive washing using sterile chilled MACS buffer Genes with an asterisk were validated with qPCR. Lists of core genes for each cluster are seen in Supplementary Table 3 . B. qPCR validation of selected genes from clusters 5, 17, 6, 7, 10, 14 and 16 in independent samples across days 0, 10, 18 and 25 of the differentiation protocol. 
